Sound Stewardship’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
1,697
-51
-3% -$6.89K 0.11% 62
2026
Q1
$223K Hold
1,748
0.1% 60
2025
Q4
$213K Buy
+1,748
New +$200K 0.1% 61
2025
Q1
Sell
-2,398
Closed -$216K 64
2024
Q4
$216K Hold
2,398
0.13% 58
2024
Q3
$237K Hold
2,398
0.13% 54
2024
Q2
$222K Buy
2,398
+21
+0.9% +$1.88K 0.14% 55
2024
Q1
$226K Sell
2,377
-228
-9% -$21.2K 0.14% 58
2023
Q4
$233K Sell
2,605
-1,188
-31% -$88.2K 0.15% 61
2023
Q3
$277K Sell
3,793
-436
-10% -$34.8K 0.19% 58
2023
Q2
$352K Hold
4,229
0.23% 50
2023
Q1
$322K Sell
4,229
-149
-3% -$12.4K 0.22% 51
2022
Q4
$363K Buy
+4,378
New +$354K 0.27% 48

Other funds holding XBI

Sound Stewardship's XBI Position: Q2 2026 in Review

Sound Stewardship reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.9% in Q2 2026, selling an estimated $6.89K and leaving 1,697 shares worth $269K. The position accounts for 0.11% of the portfolio, ranked #62.

Sound Stewardship first reported a position in XBI in Q4 2022 and has held it in 12 quarters since. The position peaked at $363K in Q4 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Sound Stewardship held 1,697 shares of State Street SPDR S&P Biotech ETF worth $269K as of Q2 2026.
  • Sound Stewardship sold 51 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $6.89K.
  • State Street SPDR S&P Biotech ETF made up 0.11% of Sound Stewardship's portfolio in Q2 2026, its #62 holding.
  • Sound Stewardship first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 12 quarters since.
  • Sound Stewardship's State Street SPDR S&P Biotech ETF position peaked at $363K in Q4 2022.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sound Stewardship's 13F filing for Q2 2026, filed 13 Jul 2026.